tldrdailynews.com logo

J&J's Kenvue IPO prices at $22 per share.

1 min read
Source: MarketWatch
J&J's Kenvue IPO prices at $22 per share.
Photo: MarketWatch
TL;DR

Johnson & Johnson's Kenvue unit is set to have the biggest IPO since 2021, with a valuation of over $40 billion. The IPO will raise more than all other IPOs combined that have made it to market in 2023. Kenvue will hold consumer brands such as Band-Aid, Tylenol, and Listerine. J&J will continue to own about 92% of Kenvue and plans to distribute the remaining shares to its own shareholders in a deal that may come in the second half of the year.

Topics:business#business#consumer-brands#ipo#johnson-and-johnson#kenvue#valuation
Share this article
  1. Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion  MarketWatch
  2. J&J spinoff Kenvue prices IPO at $22, toward the top end of expected range  CNBC
  3. Johnson and Johnson IPO Today – Consumer Healthcare Unit Starts Trading at $22  TipRanks
  4. J&J’s Kenvue Prices IPO at $22 Per Share  Yahoo Finance
  5. J&J Prices Consumer Unit IPO at $22 a Share  The Wall Street Journal

Want the full story? Read the original reporting

Read on MarketWatch